Adjunct Professor @ Moores UCSD Cancer Center - Department of Radiation Medicine and Applied Science (July 2015 - Present)
Advisory Board Member @ European Society for Translational Medicine (EUSTM) (February 2013 - Present)
President, Medical and Scientific Affairs; Interim Chief Medical Officer @ (June 2015 - July 2025)
Director, Immunotherapy and Translational Oncology @ (November 2010 - June 2015)
Principal Investigator, Director, Laboratory of Tumor Immunology and Immunotherapy @ Moores UCSD Cancer Center (July 2000 - June 2015)
SAB Member @ Medistem Inc. (January 2008 - December 2014)
VP community @ (January 2008 - January 2010)
Research Scientist @ (February 1995 - June 2000)
Boris Minev Education
National Cancer Institute, Bethesda, MD, USA
Postdoctoral (Tumor Immunology)
1992-1994
The Weizmann Institute, Rehovot, Israel
Postdoctoral (Tumor Immunology)
1991-1992
School of Medicine - Sofia, Bulgaria
M.D. (Medicine, Immunology)
1982-1988
Boris Minev Skills
Cancer
Tumor Immunology
Immunotherapy
Immuno-Oncology
Oncology
Immunology
Stem Cells
Translational Medicine
Cell
Cell Biology
Molecular Biology
Biochemistry
Biotechnology
Cancer Stem Cells
Biomarkers
Cell Culture
Assay Development
Life Sciences
Flow Cytometry
Cancer Research
In Vitro
Drug Discovery
Lifesciences
In Vivo
Translational Research
Genomics
ELISA
Monoclonal Antibodies
Immunoassays
Protein Chemistry
Proteomics
Nanotechnology
qPCR
Animal Models
Tissue Culture
Molecular Cloning
Biopharmaceuticals
Transfection
Immunohistochemistry
Virology
Regenerative Medicine
Clinical Development
Antibodies
RT-PCR
Cell Therapy
Immunofluorescence
Fluorescence Microscopy
Tumor Immunology & Immunotherapy
Stem Cell Biology
Circulating Tumor Cells
Immuno Oncology
Management
Tumor Immunology and Immunotherapy
Leadership
Chemistry
Rt Pcr
Strategy
Boris Minev Summary
Boris Minev, based in San Diego, CA, US, is currently a Chief Scientific Officer at CureScience Institute. Boris Minev brings experience from previous roles at Moores UCSD Cancer Center - Department of Radiation Medicine and Applied Science, European Society for Translational Medicine (EUSTM), Calidi Biotherapeutics and Genelux Corporation. Boris Minev holds a 1992 - 1994 Postdoctoral in Tumor Immunology @ National Cancer Institute, Bethesda, MD, USA. With a robust skill set that includes Cancer, Tumor Immunology, Immunotherapy, Immuno-Oncology, Oncology and more. Boris Minev has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Boris Minev?
Find contact details for 700 million professionals.